OTCMKTS:LHDXQ Lucira Health (LHDXQ) Stock Price, News & Analysis $0.0001 +0.00 (+∞) As of 10/4/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Lucira Health Stock (OTCMKTS:LHDXQ) Get Lucira Health alerts:Sign Up Key Stats Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.00▼$1.45Volume20,900 shsAverage Volume7.18 million shsMarket Capitalization$4.06 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Lucira Health, Inc. is a developer of rapid molecular diagnostic tests designed for use in home and point-of-care settings. Headquartered in Emeryville, California, the company leverages proprietary reverse transcription–loop-mediated isothermal amplification (RT-LAMP) technology to deliver single-use, instrument-free assays. Its flagship product, the Lucira COVID-19 All-In-One Test Kit, enables users to collect a nasal swab sample, run the test on-site and obtain results in under 30 minutes without the need for a laboratory. In December 2020, Lucira Health received emergency use authorization (EUA) from the U.S. Food and Drug Administration for its COVID-19 test kit. The company rapidly expanded commercial availability through partnerships with national pharmacy chains, online retailers and direct-to-consumer channels, making at-home molecular testing broadly accessible across the United States. Lucira’s platform is inherently adaptable, and the company has signaled plans to pursue additional respiratory pathogen assays as regulatory approvals and market demand evolve. While primarily serving the North American market, Lucira Health has explored distribution opportunities in select international regions and continues to seek regulatory clearances abroad. The company’s management team draws on extensive experience in diagnostics, consumer health and medical device commercialization, underscoring its commitment to advancing accessible, high-performance testing solutions that reduce dependency on centralized laboratory infrastructure.AI Generated. May Contain Errors. Read More Receive LHDXQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lucira Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LHDXQ Stock News HeadlinesHealthcare bankruptcies slow after peaking in 2023: reportAugust 24, 2024 | msn.comU.S. govt. to restart program to ship free at-home COVID testsSeptember 20, 2023 | msn.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.July 16 at 1:00 AM | Porter & Company (Ad)Best Senior Dating Sites Of 2023August 3, 2023 | forbes.comRemember Lucira Health's 30 Minute Home Test Kit? Pfizer Just Bought the Bankrupt Company Via Winning Auction BidApril 28, 2023 | benzinga.com8-K: Lucira Health, Inc.April 20, 2023 | marketwatch.comBankruptcy court bidder for Covid-flu test maker Lucira objects to planned sale to PfizerApril 11, 2023 | bizjournals.comPfizer to buy Covid-flu test developer Lucira Health out of bankruptcy courtApril 7, 2023 | bizjournals.comSee More Headlines LHDXQ Stock Analysis - Frequently Asked Questions How have LHDXQ shares performed this year? Lucira Health's stock was trading at $0.0001 at the beginning of 2026. Since then, LHDXQ shares have increased by 0.0% and is now trading at $0.0001. How were Lucira Health's earnings last quarter? Lucira Health, Inc. (OTCMKTS:LHDXQ) posted its quarterly earnings data on Thursday, November, 11th. The company reported ($0.47) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.51) by $0.04. The firm earned $14.98 million during the quarter, compared to analyst estimates of $18 million. How do I buy shares of Lucira Health? Shares of LHDXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/11/2021Today7/16/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolOTCMKTS:LHDXQ CIK1652724 Webwww.lucirahealth.com Phone510-350-8071FaxN/AEmployees221Year Founded2013Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$93.06 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$4.81 per share Price / Book0.00Miscellaneous Outstanding Shares40,600,000Free Float28,257,000Market Cap$4.06 thousand OptionableNot Optionable Beta2.60 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:LHDXQ) was last updated on 7/16/2026 by MarketBeat.com Staff. From Our PartnersThe Lithium Gold Rush Minted A New $1B UnicornThe Lithium Gold Rush Minted A New $1B Unicorn This lithium producer surpassed a $1B private valuation, joi...EnergyX | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredThe only metrics you should watch as a day trader.Day traders and swing traders don't need the same metrics - and using the wrong ones costs you edge. After 40 ...The TradingPub | SponsoredURGENT Dollar Reset Warning for MondayA 50-year U.S.-Saudi arrangement established under Henry Kissinger - one credited with anchoring the dollar in...Golden Portfolio | SponsoredTrump’s $250 Bill – See ImmediatelyFormer Goldman Sachs VP Dr. David Eifrig is warning that July 28 could trigger the biggest wealth reset in mod...Stansberry Research | SponsoredBlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely, LLC | SponsoredVWAV: Is This the Next Defense Breakout?VisionWave Holdings (NASDAQ: VWAV) is developing a full-stack defense technology platform integrating AI, RF s...Equiscreen | SponsoredWhen I found Rolls-Royce under $2, most people thought I was crazyIn 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucira Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucira Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
